SAN DIEGO, Jan. 9, 2025 /PRNewswire/ — Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Nextracker Inc. (NASDAQ: NXT) common stock between February 1, 2024 and August 1, 2024. Nextracker provides…

Mountainfield Venture Partners, a biopharmaceutical company creation firm, partners with Keymed Biosciences to form Timberlyne Therapeutics, accessing global development and commercial rights outside of greater China for CM313 Financing co-led by Abingworth, Bain Capital Life Sciences,…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.